Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023621
Filing Date
2017-11-14
Accepted
2017-11-13 19:56:37
Documents
83
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q orex-10q_20170930.htm 10-Q 2266224
2 EX-10.1 orex-ex101_171.htm EX-10.1 61678
3 EX-10.2 orex-ex102_125.htm EX-10.2 42627
4 EX-10.3 orex-ex103_130.htm EX-10.3 25509
5 EX-10.4 orex-ex104_126.htm EX-10.4 42947
6 EX-10.5 orex-ex105_128.htm EX-10.5 51403
7 EX-10.6 orex-ex106_127.htm EX-10.6 42445
8 EX-10.7 orex-ex107_129.htm EX-10.7 47925
9 EX-10.8 orex-ex108_311.htm EX-10.8 94366
10 EX-10.9 orex-ex109_312.htm EX-10.9 38377
11 EX-10.10 orex-ex1010_313.htm EX-10.10 43890
12 EX-10.11 orex-ex1011_314.htm EX-10.11 45495
13 EX-31.1 orex-ex311_6.htm EX-31.1 8112
14 EX-31.2 orex-ex312_8.htm EX-31.2 8456
15 EX-32.1 orex-ex321_9.htm EX-32.1 4557
16 EX-32.2 orex-ex322_7.htm EX-32.2 4738
  Complete submission text file 0001564590-17-023621.txt   9113698

Data Files

Seq Description Document Type Size
17 XBRL INSTANCE DOCUMENT orex-20170930.xml EX-101.INS 1927380
18 XBRL TAXONOMY EXTENSION SCHEMA orex-20170930.xsd EX-101.SCH 61131
19 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20170930_cal.xml EX-101.CAL 69327
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orex-20170930_def.xml EX-101.DEF 226348
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20170930_lab.xml EX-101.LAB 457282
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20170930_pre.xml EX-101.PRE 359155
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33415 | Film No.: 171197941
SIC: 2834 Pharmaceutical Preparations